CLINICAL_TRIALS
trial_result
· 2015-01-06
Clinical Trial Update: Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects [Phase 1]
Summary
Phase 1 study assessing pharmacokinetics and tolerability of Rufinamide in healthy Chinese subjects has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Seizures | Phase 1 | Status: COMPLETED